Therapeutic potential of steroids for CNS disorders

Bibliography

• GALLO R, STOMATI M, SPINETTI A, PETRAGLIA F, GENAZZANI AR: Central nervous system. Haridb. Exp. Pharmacol. (1999) 135/11:151–162.
   Google Scholar
• PRICE EH: Increased risk of mental illness and suicide in oral contraceptive and hormone replacement therapy studies. Num. Erivirori. Med. (1998) 8(2):121–127.
   Google Scholar
• BAECKSTROEM T: Symptoms related to the menopause and sex steroid treatments. Ciba Found Symp. (1995) 191:171–186.
   PubMedGoogle Scholar
• ALMEIDA OP, BARCLAY L: Sex hormones and their impact on dementia and depression: a clinical perspective. Expert Opiri. Pharmacother. (2001) 2(4):527–535.
   PubMedGoogle Scholar
• SCHUMACHER M, AKWA Y, GUENNOUN R etal.: Steroid synthesis and metabolism in the nervous system: trophic and protective effects. j Neurocytol. (2000) 29(5/6):307–326.
   Google Scholar
• COMPAGNONE NA, MELLON SH: Neurosteroids: biosynthesis and function of novel neuromodulators. Front. Neuroeridocrinol. (2000) 21(1):1–56.
   PubMed Web of Science ®Google Scholar
• ZORUMSKI CF, MENNERICK S, ISENBERG KE, COVEY DF: Potential clinical uses of neuroactive steroids. Curl: Opiri. Invest. Drugs (2000) 1(3):360–369.
   PubMedGoogle Scholar
• ••Review of neurosteroids and neuroactivesteroids.
   Google Scholar
• CYR M, CALON E MORISETTE M, M, CALLIER S, DI PAOLO T: Drugs with estrogen-like potency and brain activity: potential therapeutic application for the CNS. Curl: Pharm. Dec. (2000) 6(12):1287–1312.
   PubMed Web of Science ®Google Scholar
• •Comprehensive review on CNS actions of oestrogens.
   Google Scholar
• GREEN PS, SIMPKINS JW: Neuroprotective effects of estrogens: potential mechanisms of action. Int. j Dev. Neurosci. (2000) 18(4-5):347–358.
   PubMed Web of Science ®Google Scholar
• FINK G, SUMNER BEH, MCQUEEN JK, WILSON H, ROSIER: Sex steroid control of mood, mental state and memory. OM. Exp. Pharmacol. Physiol. (1998) 25(10):764–775.
   PubMedGoogle Scholar
• ELGER W, PALME H-J, SCHWARZ S: Novel estrogen sulfamates: a new approach oral hormone therapy. Expert Opiri.Irivestig. Drugs (1998) 7(4):575–589.
   PubMedGoogle Scholar
• OSTERLUND MK, HURD YL: Estrogen receptors in the human forebrain and the relation to neuropsychiatric disorders. Frog. Neurobiol. (2001) 64(3):251–267.
   Google Scholar
• SVEC E PORTER JR:: a nutritional supplement with actions in the central nervous system. Nut. Neurosci. (1998) 1(1):9–19.
   PubMedGoogle Scholar
• ROSE KA, STAPLETON G, DOTT K et al: Cyp7b, a novel brain cytochrome P450, catalyzes the synthesis of neurosteroids 7a-hydroxy dehydroepiandrosterone and 7a-hydroxy pregnenolone. Proc. Nati Acad. Sci. USA. (1997) 94(10):4925–4930.
   PubMedGoogle Scholar
• DE NICOLA AE FERRINI M, SL et al.: Regulation of gene expression by corticoid hormones in the brain and spinal cord. j Steroid Biochem. Md. Biol. (1998) 65(1-6):253–272.
   PubMedGoogle Scholar
• WOLKOWITZ OM, REUS VI, CANICK J, LEVIN B, LUPIEN S: Glucocorticoid medication, memory and steroid psychosis medical illness. Ann. N 1/.- Acad. Sci. (1997) 823:81–96.
   Google Scholar
• LUCASSEN PJ, DE KLOET ER: Glucocorticoids and the aging brain: cause or consequence? Funct. Neuronic] Aging. Hof PR, Mobbs CV (Ed): Academic Press. (2000:883–905.
   Google Scholar
• SAPOLSKY RM: Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch. Gen. Psychiatry (2000) 57(10):925–935.
   PubMed Web of Science ®Google Scholar
• SECKL JR, WALKER BR: Minireview: 1113-hydroxysteroid dehydrogenase Type 1 - A tissue-specific amplifier of glucocorticoid action. Endocrinology (2001) 142(4):1371–1376.
   PubMed Web of Science ®Google Scholar
• MAURICE T, PHAN V-L, URANI A, KAMEI H, NODA Y, NABESHIMA T: Neuroactive neurosteroids as endogenous effectors for the sigmal (an receptor: Pharmacological evidence and therapeutic opportunities. fpri. I Pharmacol (1999) 81(2):125–155.
   Google Scholar
• BERGERON R, DE MONTIGNY C, DEBONNEL G: Potentiation of neuronal NMDA response induced by dehydro-epiandrosterone and its suppression by progesterone: effects mediated via sigma receptors. j Neurosci. (1996) 16(3):1193–1202.
   PubMedGoogle Scholar
• MONAGHAN EP, MCAULEY JW, DATA JL: Ganaxolone: a novel positive allosteric modulator of the GABAA receptor complex for the treatment of epilepsy. Expert Opin. Investig. Drugs. (1999) 8(10):1663–1671.
   PubMedGoogle Scholar
• •Clinical status of the anticonvulsant neurosteroid derivative ganaxolone.
   Google Scholar
• DUBROVSKY B: The specificity of stress responses to different nocuous stimuli: neurosteroids and depression. Brain Res. Bull. (2000) 51(6):443–455.
   PubMedGoogle Scholar
• SMITH SS, GONG QH, HSU F-C et al.: GABAA receptor a4 subunit suppression prevents withdrawal properties of an endogenous steroid. Nature (1998) 392(6697):926–930.
   PubMedGoogle Scholar
• CECCON M, RUMBAUGH G, VICINI S: Distinct effect of pregnenolone sulfate on NMDA receptor subtypes. Neuropharmacology (2001) 40:491–500.
   PubMedGoogle Scholar
• WEAVER CE, LAND MB, PURDY RH, RICHARDS KG, GIBBS TT, FARB DH: Geometry and charge determine effects of steroids on IV methyl-D-aspartate receptor-induced Ca2+ accumulation and cell death. j Pharmacol. Ther. (2000) 293(3):747–754.
   PubMedGoogle Scholar
• WEAVER CE, MAREK P, PARK-CHUNG M, TAM SW, FARB DH: Neuroprotective activity of a new class of steroidal inhibitors of the N-methyl-D-aspartate receptor. Proc. Natl. Acad. Sci. USA (1997) 94(19):10450–10454.
   PubMedGoogle Scholar
• JOHNSON DA, WU T-H, LI P-K, MAHER TJ: The effect of steroid sulfatase inhibition on learning and spatial memory. Brain Res. (2000) 865(2):286–290.
   PubMedGoogle Scholar
• VEENMAN L, GAVISH M: Peripheral-type benzodiazepine receptors: their implication in brain disease. Drug Dev. Res (2000) 50(3/4):355–370.
   Google Scholar
• AMRI H, OGWUEGBU SO, BOUJRAD N, DRIEU K, PAPADOPOULOS V: In vivo regulation of peripheral-type benzodiazepine receptor and glucocorticoid synthesis by Ginkgo biloba extract EGb 761 and isolated ginkgolides. Endocrinology (1996) 137(12):5707–5718.
   PubMedGoogle Scholar
• SERRA M, MADAUP, CHESSA MF et aL:2-Phenyl-imidazo [1,2-alpyridine derivatives as ligands for peripheral benzodiazepine receptors: stimulation of neurosteroid synthesis and anticonflict action in rats. Br. (1999) 127(1):177–187.
   Google Scholar
• ZHI L, MARSCHKE KB: Novel class of non-steroidal progesterone receptor antagonists. Expert Opin. Ther. Pat. (1999) 9(6):695–700.
   Web of Science ®Google Scholar
• HALL ED: Lazaroids: mechanisms of action and implications for disorders of the CNS. Neuroscientist (1997) 3(1):42–51.
   Google Scholar